Nearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their cancer returning at the 2½-year mark.
Moderna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with a deadly form of skin cancer.
The shot is a key part of Moderna's pipeline that has helped shore up investor sentiment for the biotech company following a rocky last year, when demand plummeted for its Covid vaccine,Among new data, nearly 75% of patients who took the combination were alive without any signs or symptoms of their cancer returning at the 2½-year mark. That compares with 55.6% of patients who got Keytruda alone.
As the companies previously announced, patients with severe forms of the cancer, known as melanoma, who received the combination were 49% less likely to die or have their cancer return than those who took Keytruda alone after roughly three years. The combination also slashed the risk of melanoma spreading to other parts of the body, or death, by 62%.
Moderna is excited about working to reduce the time between the initial analysis of a tumor and when a patient gets injected with the shot, CEO Stephane Bancel said in an interview with CNBC.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
75 Soft Challenge: Learn 75 Soft Rules, Easier Version Of 75 HardA. Pawlowski is a TODAY health reporter focusing on health news and features. Previously, she was a writer, producer and editor at CNN.
Read more »
Best Buy has a Samsung 75-inch TV for only $700 todayLooking for a great TV for less? Best Buy has a Samsung 75-inch 4K TV for $700 and it's packed with picture improving features.
Read more »
Turkey's inflation passes 75% in what economists believe is peakInflation in Turkey topped 75% in May in what economists expect to be the peak before prices start to ease.
Read more »
75-year-old John Force races to record 157th NHRA victory at New England NationalsJohn Force raced to his record 157th NHRA victory Sunday at age 75, beating teammate Austin Prock in the Funny Car final at the NHRA New England Nationals.
Read more »
75-year-old John Forces races to a record 157th NHRA victoryJohn Force records his 157th NHRA victory Sunday at age 75, beating teammate Austin Prock in the Funny Car final at the NHRA New England Nationals.
Read more »
75-year-old John Forces races to record 157th NHRA victory at New England NationalsJohn Force raced to his record 157th NHRA victory Sunday at age 75, beating teammate Austin Prock in the Funny Car final at the NHRA New England Nationals. Force had a 4.081-second run at 319.29 mph in his Chevrolet Camaro SS, while Prock ran a 4.096 at 316.38. Force won for the second time this season and the third time at New England Dragway.
Read more »